CNSoc's 12th Annual National Symposium

Cambridge Neurological Society

PROUDLY PRESENTING

Find out more

About the Symposium

Symposium Speakers

The National CNS Symposium,

is an annual symposium that hosts 150-200 delegates, including PhD students, medical students, trainees, PIs and consultants from all over the nation and from abroad.

We have organised a great programme ahead, featuring an excellent selection of speakers from across Neuroscience, Neurology, and Neurosurgery. On top of this, we will be running workshops and give students an opportunity to present their research!

DETAILS

DATE: 1st April

TIME: 8am - 5pm

LOCATION: Clinical School at Addenbrookes/Cambridge Biomedical Centre

EVENTS OF THE DAY:

Renowned guest speakers
4 workshops
Student Talks
Poster Presentation Exhibition
Formal Dinner at St. John's College

Alongside coffee and lunch breaks

Symposium Speakers' Affiliations

Cambridge University

Oxford University

UCL University

Imperial College London

King's College London

UCL Queen's Square Institute of Neurology

Alder Hey Children's Hospital

Liverpool University

NANSIG

Proudly Presenting

Our Sponsors

Proudly Presenting

Our Sponsors

Olympus is a global MedTech company that is relentless in its pursuit of excellence, constantly striving to deliver the highest quality solutions in everything we do. With society's needs always changing, our passion to contribute to the health and well-being of people worldwide motivates us to remain flexible and agile in our search for the best solutions.

Through this approach, and together with Healthcare Professionals we can make people's lives healthier, safer and more fulfilling.

“World Precision Instruments (WPI) is a leading instrument and equipment manufacturer specialized in supporting neuroscience, physiology, electrophysiology and cell imaging research.

We offer a complete line of neuroscience equipment including microinjectors, stereotaxic systems, stimulators, amplifiers, data acquisition, micromanipulators, loupes and surgical instruments.

WPI’s products for neurosciences applications have 1000s of citations and include the UMP3T-1 for stereotaxic injections and our new Live Cell Imaging system AutoLCI.

For essential fluidic control, we offer solutions across pumping platforms including syringe, peristaltic, microfluidic and pneumatic microinjection pumps for picoliter to microliter flow.

Come and visit our booth to discuss your applications and discover our latest innovations in Neuroscience and Cell Imaging.” www.wpi-europe.com

Proudly Presenting

Our Sponsors

BK Medical provides reassurance for decision-making in neurosurgery. Whether you specialize in neuro-oncology, spine, neurovascular, functional, or pediatrics, use real-time intraoperative ultrasound to achieve planned results. bkActiv is our newest generation of active imaging that helps neurosurgeons visualize anatomy in real-time.

VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside..

Proteintech is a leading manufacturer of antibodies, immunoassays, proteins and Nanobodies.

Proteintech’s comprehensive library of original validation data, product-specific protocols, and over 150,000 product citations enables you to publish faster with reproducible results.

All products are in stock and available for next-day delivery.

Proudly Presenting

Our Sponsors

Biology Open (BiO) is an Open Access journal that publishes rigorously conducted high-quality research across the breadth of the biological and biomedical sciences. It provides timely, thorough, constructive and fair peer review, with a focus on supporting researchers and reducing the pain to publish. Our international board of research-active academic Editors, led by Editor-in-Chief Steven Kelly, comprises leaders in their respective fields. The BiO team is committed to Open Access publishing as a mechanism to widen access, promote equality and ensure sustainability in publishing in the biological and biomedical sciences.

StemBond Technologies are a spin-out from the Cambridge Stem Cell Institute. Our mission is to leverage advanced materials science to control cell fate and function. We will exploit this ability to advance the field of Regenerative Medicine.

Proudly Presenting

Our Sponsors

STEMCELL Technologies develops specialty cell culture media, cell isolation products, and accessory reagents for life science research.

Model the human brain in 3D with STEMdiff ™ Cerebral Organoid Kit and our brain-region-specific organoid kits. Use BrainPhys ™ Neuronal Medium to culture active neurons in a physiological environment. Try NeuroCult ™ media and supplements for primary and CNS-derived neural stem cells. For human neurological disease modeling, the STEMdiff ™ Neural System supports your iPS-neural workflow, from neural induction to downstream differentiation. Visit the STEMCELL booth to learn more.

Our aim is to understand the nervous system in both health and disease in order to develop new treatments for incurable neurological disorders. Embedded within Cambridge University Hospitals, our research aims to solve problems we have encountered in the clinic, and directly address the needs of patients and families. Working in close partnership with the Departments of Psychiatry, Genetics and Paediatrics, we use innovative cross-cutting technologies which link the laboratory and the clinic to unravel the mechanisms of brain disease that impact from childhood to old-age. We use genetics and genomics, to study rare and common neurological diseases, cell biology and human stem cells, model organisms, and state-of-the-art human brain imaging through the Wolfson Brain Imaging Centre, which we host along with a UK Dementia Research Institute centre.

New treatments, tested in the clinic, are now in use world-wide. These include; immunological treatments against brain inflammation including multiple sclerosis; surgical and metabolic interventions to reduce the impact of head injury; understanding the causes and consequences of stroke; preventing the loss of vision and hearing; and developing new treatments to stop neurodegeneration and dementias including Parkinson’s disease and Alzheimer’s disease.